For Immediate Release
Advancing Technologies for Using Cells as Biofactories
Contact: Kathryn Ryan
914-740-2250
kryan@liebertpub.com
New Rochelle, NY, September 27, 2023—A new comprehensive review published in the peer-reviewed journal Industrial Biotechnology examines how industrial biotechnology and biopharmaceutical manufacturing utilize the same framework for efficient biochemical production, which can be leveraged in current and future collaborations to enable rapid innovation. Click here to read the article now.
In the article titled “Cells as Biofactories: Parallels Between Biopharmaceutical Manufacturing and Industrial Biotechnology,” Lauren Cordova and Kelvin Lee, from the University of Delaware, describe advances in synthetic biology, genetic engineering, including CRISPR and sequencing technologies, and strain/clone development, and high-throughput screening, that have contributed to rapid progress in new product development and innovation in both biopharmaceutical manufacturing and industrial biotechnology.
The authors discuss mechanisms for cross-disciplinary innovation and point to consortia groups that have been created to promote and further develop technology. “With additional collaboration through these groups and new partnerships, future innovation can bridge industrial biotechnology and biopharmaceutical manufacturing to more rapidly engineer cells as efficient biofactories,” state the authors.
“Cordova and Lee raise important points about the commonalities of tools and techniques that are used in industrial biotechnology and biopharmaceutical manufacturing. Indeed, scientific and engineering communities engaged in these activities are highly fragmented. This is revealed by specialized sessions at meetings and identification of scientists/engineers as working in either industrial biotechnology or biopharmaceutical manufacturing” says Editor-in-Chief Richard A. Gross, PhD.
About the Journal
Industrial Biotechnology, led by Editor-in-Chief Richard A. Gross, PhD, Chair, Biocatalysts and Metabolic Engineering Constellation, Rensselaer Polytechnic Institute, is an authoritative journal focused on biobased industrial and environmental products and processes, published bimonthly in print and online. The Journal reports on the science, technology, business, and policy developments of the emerging global bioeconomy, including biobased production of energy and fuels, chemicals, materials, and consumer goods. The articles published include critically reviewed original research in all related sciences (biology, biochemistry, chemical and process engineering, agriculture), in addition to expert commentary on current policy, funding, markets, business, legal issues, and science trends. Industrial Biotechnology offers the premier forum bridging basic research and R&D with later-stage commercialization for sustainable biobased industrial and environmental applications.
About the Publisher
Mary Ann Liebert, Inc. is a global media company dedicated to creating, curating, and delivering impactful peer-reviewed research and authoritative content services to advance the fields of biotechnology and the life sciences, specialized clinical medicine, and public health and policy. For complete information, please visit the Mary Ann Liebert, Inc. website.